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Abstract 
Antibiotic associated diarrhea (AAD) is defined as the self limiting diarrhea that occurs during or 
following a course of antibiotics (Bartlett, 2002; Dendukuri, Costa, McGregor, & Brophy, 2005; 
Pimental & Choure, 2009; Sullivan & Nord, 2005; Vrabie & Aberra, 2009).  Despite strong 
support for the use of probiotics in the outpatient setting for preventing AAD, there is lack of 
probiotic utilization by primary care providers in the outpatient setting.  Current literature 
indicates that one of the barriers to probiotic use is medical doctors’ (MDs) and nurse 
practitioners’ (NPs) attitude and lack of knowledge regarding the use of probiotics in preventing 
antibiotic associated diarrhea.  The purpose of this study was to evaluate the current attitude and 
knowledge of providers (MD, NP and physician assistant [PA]) in a primary care practice in 
central and eastern Connecticut.  Current attitude towards of the use of probiotics to prevent 
AAD was positive (p=0.083).  The level of providers knowledge increased by 17.53% (p=0.002). 
NPs showed a greater increase in knowledge in the post test than MDs (F(21)=59.345, p=0.005).  
The second purpose of the study was to introduce an evidence-based protocol, during an 
educational intervention, for use in the adult outpatient setting.  The third purpose of the study 
was to evaluate providers’ use of probiotics as documented in the Electronic Medical Record 
after the introduction of an educational intervention.  There was a 50% increase in the number of 
providers recommending probiotics when prescribing an antibiotic. The result of this study 
showed providers have a positive attitude toward the use of probiotics to prevent AAD.  There 
was also an increase in the provider knowledge of probiotic use after an educational intervention 
and the introduction of an evidence-based protocol.  There was also an increase in the number of 
providers who recorded their recommendation of a probiotic when prescribing an antibiotic.   
Educational programs can be successful in introducing any evidence-based protocol.  Further 
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research is needed to evaluate if this increase in the use of probiotics is sustained.  Further 
research is also needed to evaluate the extent providers implement the evidence-based protocol 
within their practice. 
  
USE OF PROBIOTICS TO PREVENT ANTIBIOTIC ASSOCIATED DIARRHEA  8 
Problem 
Statement of the Problem 
Many episodic visits to primary care providers are due to complaints related to an 
infective process; cellulitis, sinusitis, community acquired pneumonia, etc.  These are 
appropriate and reasonable conditions for antibiotic treatment.  All antibiotics have the potential 
side of effect of diarrhea which puts the patient at risk for antibiotic associated diarrhea (AAD), 
this risk is increased if the patient has co-morbidities or advanced age.  Preventing AAD 
improves patient health outcomes.  The current treatment for AAD is to stop the prescribed 
antibiotic; evidence supports AAD prevention by adding a probiotic to the treatment regime.  
Probiotics have not been used widely or consistently in the adult outpatient setting.  One of the 
barriers to probiotic use is lack of provider knowledge of probiotics to prevent AAD.  The 
purpose of this study is to discover what providers attitude and knowledge about probiotics and 
if an educational intervention increases probiotic use in the outpatient adult setting.  
AAD affects one in five adults prescribed antibiotics (Avadhani & Miley, 2011; 
Weichseilbaum, 2009).  When a probiotic is taken concurrently with an antibiotic, AAD is 
reduced to one in ten adults (Avadhani & Miley, 2011; Weichseilbaum, 2009).  Several meta-
analyses support the use of probiotics to prevent AAD in the adult population (Avadhani & 
Miley, 2011; Cremonini, et al, 2002; D’Souza, Rajkumar, Cooke, & Bulpitt 2002; Kale-Pradhan, 
Jassal & Wilhelm 2010; McFarland 2010; Sazawal, et al 2006; Szajewska & Mrukowicz 2005).  
Only a few studies specifically describe the use of probiotics in the adult outpatient population 
(Armuzzi, et al., 2001).  The evidence supports the use of probiotics to prevent AAD in the adult 
outpatient population.  It is not clear if probiotics are currently used by primary care providers. 
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Information discussing provider attitude and knowledge in the use of probiotics to 
prevent AAD is minimal.  Hermosilla (2009) reports that after an educational session there was 
an increase in probiotic prescribing in a medical intensive care unit.  Camras (2008) proposed an 
educational project to be done at an adult primary care practice however results were not 
reported in her paper.  Nichols, Grobe and Roche (2005) report on a web based survey they used 
to determine what advice general practitioners give to patients regarding probiotics.  Nichols, et 
al. concludes that greater than 50% of the general practitioners advise probiotics in certain 
clinical scenarios.  
The main purpose of this study is to evaluate the knowledge and attitude toward the use 
of probiotics to prevent AAD.  The study evaluated approximately 70 providers (MD, NP, and 
PA) in a primary care and urgent care practice located in central and eastern Connecticut.  The 
secondary purpose is to introduce an evidence-based protocol for the use of probiotics to prevent 
AAD accomplished by an in person educational intervention.  The final purpose of this study is 
to identify if knowledge increases and practice changes following the educational intervention. 
Goals of the Project 
• To get at least 50% participation from the 70 providers to complete the study. 
• To design an evidence-based protocol for the use of probiotics to prevent AAD in the 
outpatient adult setting. 
• To present an educational intervention introducing the evidence-based protocol to the 
provider staff. 
• To document and analyze current antibiotic and probiotic prescribing habits of Primary 
Care Providers. 
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• To present results to the medical staff at the conclusion of this project. 
Evidence of the Problem 
Antibiotics continue to be prescribed in large numbers.  According to the American 
College of Physicians (2011), 133 million courses of antibiotics are prescribed each year.  These 
are for wide ranging infections, e.g.: sinusitis, community acquired pneumonia, cellulitis, urinary 
tract infections, etc.  There is variation of specific antibiotic prescribed, depending on presumed 
infective bacteria, co-morbidities, and bacteria sensitivities.  The use of any antibiotic for any 
infection can cause AAD.  This indicates that increasing the number of antibiotics increases the 
incidence of AAD. 
The incidence of AAD is reported as between 5 -30% of adults prescribed antibiotics 
(Avadhani & Miley, 2011; Bartlett, 2002; Hickson, et al, 2007; Jenkins, et al 2005; McFarland, 
1998; Pimental & Choure, 2009; Sullivan & Nord, 2005; Teitelbaum & Walker, 2002; 
Weichselbaum, 2009).  These numbers represent the total incidence of AAD both inpatient and 
outpatient.  McFarland (2008) states that outpatient incident rates of diarrhea for every 100 visits 
for diarrhea 34 are for AAD. Using these reported incidences, approximately 29 million adults in 
the United States experienced AAD during a course of outpatient antibiotic treatment in the year 
2001.  Despite these numbers the true incidence of AAD in the outpatient adult population is 
higher; in a study by Gessert & Rubin (2011), they conclude that AAD is underreported.  
In the outpatient setting, antibiotic associated gastrointestinal side effects are often the 
reason a patient stops the antibiotic, but this information is not regularly reported to the provider 
by the patient (Armuzzi, et al, 2001).  Anastasio, et al, (1992) report a discontinuance rate for 
erythromycin due to diarrhea as between 4%-25%.  Damrongmane and Ukarapol (2007) report 
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two thirds of the pediatric patients with AAD the antibiotic was stopped without medical advice.  
The inpatient setting is a controlled environment; the administration of medications is controlled 
by facility practice guidelines, while there is no control in the outpatient setting.  In conclusion, 
the prevention of the side effect of AAD is averted then the full antibiotic course is likely to be 
finished.  By inference there would be a decrease in Clostridium difficile cases, as C. difficile is 
considered a subset of AAD for the purposes of this study. 
A review of the existing literature supports the prophylactic use of probiotics to prevent 
AAD in the adult inpatient setting.  In the outpatient setting there is the challenge of different 
infective processes and different antibiotic treatments.  The reviewed studies were not diagnosis 
specific nor were they antibiotic specific and most did not control for these variables.  This is 
helpful in the outpatient setting when the choice of antibiotic is generally broader for the range of 
infective processes treated.  The support of concurrent probiotic use in a wide variety of 
diagnostic and treatment combinations becomes very helpful in the outpatient adult setting 
(Armuzzi, et al, 2001; Avadhani & Miley, 2011; Cremonini, et al., 2002; Kale-Pradhan, Jassal & 
Wilhelm, 2010; McFarland, 2010; Sazawal, et al, 2006; Szajewska & Mrukowicz, 2005).   
Armuzzi, et al., (2001), Avadhani and Miley, (2011), Cremonini, et al., (2002), Kale-
Pradhan, Jassal and Wilhelm, (2010), McFarland, (2010), Sazawal, et al., (2006) and Szajewska 
and Mrukowics, (2005), all focused on reducing AAD in the inpatient setting, this speaks to a 
need for further investigation of the use of probiotics in the outpatient setting.  The conclusions 
of these meta-analyses are applicable in the outpatient setting for use of probiotics for the 
prevention of AAD.  These supplements are readily available over the counter and their use in 
the outpatient setting is relatively unknown. 
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Armuzzi, et al., (2001), is an outpatient adult study that addresses probiotic use for the 
prevention of AAD.  This study looked at 60 healthy adults who were asymptomatic, 
Helicobactor pylori positive in an outpatient setting.  Study participants were randomized to 
either probiotic or placebo while receiving standard treatment with a macrolide antibiotic; an 
antiparasitic and proton pump inhibitor.  They used Lactobacillus GG 6 x 109 CFU for 14 days, 
in the treatment arm of the study.  The probiotic was given the week of H. pylori eradication 
therapy and the week after.  They report a significant reduction of AAD, (RR=0.1; CI 95% 0.1-
0.9).  They conclude that L. GG is effective in reducing the incidence of AAD in the adult 
outpatient setting.  
It is unclear why there are so few studies of probiotics for the prevention of AAD in the 
adult outpatient setting.  The researcher proposes that probiotics are over the counter 
supplements sold direct to consumer and monetary allocation for these types of studies may not 
benefit the companies.  Studies that look at provider attitude and knowledge would direct 
educational programs to increase awareness of the benefits of probiotics.  For probiotics to be 
considered evidence based practice these studies need to be done to provide support for their use.  
Community Needs Assessment 
 In a demonstration project started in 2007, the medical team of a rural eastern 
Connecticut skilled nursing facility (SNF) noted an increase in the incidence of diarrhea.  This 
prompted a review to determine the root cause of this increase.  Increases in antibiotic usage, due 
to an outbreak of upper respiratory infection, lead to these cases of AAD.  It was felt that there 
must be a way to treat or prevent diarrhea associated with antibiotics.  The protocol shows a 
reduction in AAD to zero over a five year time frame.  This protocol consists of the 
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administration of a probiotic every time a course of antibiotics is prescribed.  The protocol 
continues to be in place at this SNF. 
 If the introduction of a probiotic can reduce AAD in the SNF population can the same 
reduction be realized in the outpatient adult setting?  It is well documented that probiotics are 
effective in reducing the incidence of AAD in the pediatric outpatient setting but there is little 
documentation supporting the use of probiotics for adults.  This gap in the literature provides an 
opportunity for research. 
Several personal discussions were undertaken with specialists within the researchers’ 
provider community.  In a discussion on November 9, 2011 the local infectious disease 
specialist, Eugene M. Ciccone, MD, agrees that there is a need for the use of probiotics in adults 
and further study is need in the outpatient adult setting.  Ajit J. Kokkat, MD, a local 
gastroenterologist, also supports the use of probiotics in the adult population and agrees that 
there is a need for further study in the population.  Dr. Kokkat reviewed and endorsed the 
proposed protocol.  The information was also reviewed by Lynn M. Rapsilber, MSN, APN-BC, 
APRN, specializes in gastroenterology; is an advocate of the use of probiotics to prevent AAD.  
Ms. Rapsilber also reviewed and endorsed the protocol.  This project was formally approved by 
Kent Stahl, MD, Chief Executive Officer and Medical Director of Hartford Medical Group.  A 
formal stakeholder letter can be found in Appendix 4.  As the medical director, Dr Stahl is 
supportive of the need for research within the adult population.  This study has also been 
discussed and approved by the office medical director, Michael A. Kilgannon, MD. 
Stakeholders 
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 Key stakeholders include the decision makers Hartford Medical Group (HMG).  These 
decision makers include the Chief Executive Officer/Chief Medical Officer, Kent Stahl, MD and 
the Chief Operating Officer, John Fundock, PA.  They supported the provided time during the 
medical staff meeting for the educational intervention.   
Review of Literature  
 Antibiotic associated diarrhea is accepted to refer to the diarrhea that occurs during or 
following a course of antibiotics (Bartlett, 2002; Dendukuri, et al, 2005; Pimental & Choure, 
2009; , Sullivan & Nord, 2005; Vrabie & Aberra, 2009).The incidence of AAD is reported as 
between 5 -30% (Bartlett, 2002; Hickson, et al, 2007; Pimental & Choure, 2009; Sullivan & 
Nord, 2005; Teitelbaum & Walker, 2002).  Bartlett (2002) breaks down these percentages by 
offending antibiotic: ampicillin, 10-25%; amoxicillin-clavulanate, 10-25%; cefixime, 15-20%; 
and all others cephalosporins, fluoroquinolones, azithromycin, clarithromycin, erythromycin, and 
tetracycline, 2-5%.  Jenkins, et al (2005) report 30% of patient can experience AAD.  For the 
purposes of this study C. difficile is considered a subset of AAD. 
Diarrhea can pose a serious problem for any patient beyond the nuisance factor.  Diarrhea 
leading to dehydration and electrolyte imbalance complicates the treatment of a simple infection.  
Add this to any potential co-morbid conditions a patient may have and a life threatening situation 
can ensue.  The prevention of all types of diarrhea associated with antibiotic use would decrease 
negative outcomes, avoid adverse events, save healthcare dollars and decrease the likelihood of 
the patient stopping the antibiotic therapy prematurely due to diarrhea.  The use of narcotics and 
antidiarrheal medications combined with the derangement of the intestinal flora has been 
postulated to potentially cause the complication of toxic mega-colon. In the outpatient setting 
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preventing diarrhea means a course of antibiotics is completed as directed, as well as both direct 
and indirect healthcare costs are reduced.  The current approach to AAD is to discontinue the 
offending antibiotic (Bartlett, 2002).   
 It is generally accepted that the cause of AAD is exposure to antibiotics, oral or 
parenteral (Bartlett, 2002; Rohde, Bartolini & Jones, 2009; Vogel, 1995; Vrabie & Aberra, 
2009).  Other risk factors include: use of fluoroquinolones, neonates born prematurely, severe 
illness, prolonged antibiotics use, nasogastric intubation, age greater than 65 years, male gender, 
use of proton pump inhibitor, medical patient, increased length of hospital stay, gastrointestinal 
surgery or gastrointestinal manipulation, immunodeficiency, narcotic use and antidiarrheal 
medications (Bartlett, 2002; Rohde, Bartolini & Jones, 2009; Vogel, 1995; Vrabie & Aberra, 
2009). 
 There are currently no clinical guidelines for the use of probiotics in the outpatient 
setting.  A search of the National Guideline Clearinghouse, the Cochrane Library, Pub Med, and 
CIAHL, from 1980 to present, yielded evidence and suggestion of probiotic use but no 
guidelines that outline safety, dosing, adverse events and recommended protocols.  A search 
using the term antibiotic associated diarrhea in the National Guideline Clearinghouse returned 61 
possible guidelines but none were specific for AAD.  The closest guideline; “World 
Gastroenterology Organisation (WGO) practice guideline: acute diarrhea,” however, this 
guideline does not address diarrhea specifically associated with antibiotics.  It does address the 
use of probiotics: “Controlled clinical intervention studies and meta-analyses support the use of 
the specific probiotic strains and products in the treatment and prevention of rotavirus diarrhea in 
infants.  However, all effects are strain-specific and need to be verified for each strain in human 
studies.  Extrapolation from the results of even closely related strains is not possible, and 
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significantly different effects have been reported” (WGO, 2008, page 9).  A search of the 
Cochrane Library found 29 citations with the search antibiotic associated diarrhea.  Two of these 
were considered applicable to this paper.  One entitled “Probiotics for the prevention of pediatric 
antibiotic-associated diarrhea” is a full review with recommendations (Johnston, Supina, Ospina, 
& Vohra, 2007).  This report is specific for the pediatric population and has limited applicability 
to the adult population.  The other report, “Probiotics for the prevention of Clostridium difficile 
antibiotic-associated diarrhea in adults and children,” is only in the development stage with no 
standards put forth at this time (Pillai & Nelson, 2008). 
Antibiotic Associated Diarrhea 
Probiotics have a role in the prevention of AAD.  A probiotic is defined by the World 
Health Organization as “Live microorganisms which when administered in adequate amounts 
confer a health benefit on the host,” (Weizman, Asli & Alsheikh, 2005; World Health 
Organization, 2001, page 5).  The Cochrane Collaboration has approved a review that states 
probiotic treatment was demonstrated to be beneficial versus placebo in the prevention of 
pediatric AAD (Johnson, et al, 2008).  The literature discussing prevention of AAD in the adult 
population using probiotics has many small studies that make comparisons between the studies 
challenging (Armuzzi, et al, 2001; Davidson, Hibberd, Calderwood, & Baron, 2009; Dendukuri, 
et al, 2005; Sullivan & Nord, 2005).  Acknowledging current studies are disparate there is 
evidence for the use of probiotic monotherapy to prevent AAD in adults in the inpatient setting 
(D’Sousza, Rajkumar, Cooke & Bulpitt, 2002; Santosa, Farnworth & Jones, 2006; Sullivan & 
Nord, 2005).  In a randomized control study (RCT) by Hickson, et al, (2007) researchers gave 
inpatients a probiotic drink that contained three different probiotics which showed a significant 
reduction in the incidence of AAD (p=0.007).  Wallace (2009) notes that a dose dependent effect 
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improved outcomes of AAD when the dose was 5.5 to 20 billion colony forming unit (CFU) per 
day.  Of the 10 studies evaluated by Wallace, five studies looked at monotherapy using 
Lactobacillus sporogenes, Lactobacillus GG or Saccharomyces boulardii and all decreased the 
incidence of AAD.  None of the studies were able to agree on which probiotic to use, dose of 
probiotic and length of use (D’Sousza, et al, 2002; Dendukuri, et al, 2005; Miller & Fraser, 
2009).  Accumulated evidence states that probiotics reduce the risk of AAD particularly the 
probiotics S. boulardii and L. GG (Wallace, 2009; Weichseilbaum, 2009).  Avadhani and 
Miley’s (2011) meta-analysis concludes that probiotics provide a relative risk reduction of 44% 
for AAD. 
 The following is a review of the seven meta-analyses found during literature search.  
These meta-analyses focus on the adult inpatient population although some did include the 
pediatric inpatient and outpatient population.  There is one RCT on AAD in the outpatient adult 
population, this study is also described.  
Avadhani and Miley’s (2011) meta-analysis includes eight RCT evaluating probiotic 
efficacies in the prevention of AAD.  They include two studies that report negative results with 
respect to the use of probiotics in preventing AAD.  The perspective of this meta-analysis is 
prevention of AAD and C. difficile-associated diarrhea (CDAD) in hospitalized adults.  This 
review paper focused on their results for AAD.  All eight of the articles include results for AAD.  
A random effects model in the MAStARI software and the Mantel-Haenszel relative risk ratio 
was used to analyze the eight studies.  The Forest Plot showed an overall favoring of probiotics 
in the prevention of AAD.  They report an overall Z=4.75 with a p ≤ 0.001.  The relative risk 
ratio was 0.56 (95% CI, 0.44-0.71).  They do report heterogeneity as being low to moderate 
(29.12) owing to the fact that two studies had negative results.  No funnel plot was reported.  
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They conclude concurrent use of probiotics was effective in preventing AAD in the adult 
hospitalized patient. 
 Cremonini, et al, (2002) review seven RCT for their meta-analysis and report an age 
range of two weeks to elderly age groups.  This analysis also includes a study with negative 
results; it is the same study that is reported as negative in the previous meta-analysis.  This 
review does not stratify the studies evaluated for setting; this information was extracted from the 
discussion and the studies themselves when available.  These authors investigated probiotic 
monotherapy to prevent AAD.  There were two different probiotics represented in this analysis: 
Lactobacillus GG and S. boulardii. The Forest Plot showed an overall favoring of probiotics in 
the prevention of AAD.   This data was analyzed using STATA Software version 6.0 from Texas 
University.  An overall Z score was not reported.  The test for homogeneity gave X2 = 6.001; df = 
6; p = 0.42.  Mantel-Haenszel was used to calculate the combined relative risk reported as 0.3966 
(95% CI, 0.275-0.571).  This study reported a funnel plot with no asymmetry observed.  These 
authors conclude probiotics reduce the risk of AAD. 
 D’Souza, Rajkumar, Cooke, & Bulpitt (2002) present a meta-analysis that evaluated the 
efficacy of probiotics in the prevention and treatment of AAD.  This analysis included pediatrics 
and adults, two of the studies report pediatric results.  This meta-analysis utilized the QUOROM 
statement.  The outcome measure is the percentage of patients in either arm of the study without 
diarrhea.  They also performed three separate analyses split by probiotics type: S. boulardii and 
lactobacilli or enterococci. A pooled analysis of all nine studies is also included in the 
discussion.  The Mantel-Haenszel method is applied to determine the benefit of treatment versus 
placebo.  No publication bias is shown in the funnel plot.  The relative risk for all nine studies is 
reported as 0.37 (95% CI; 0.26 – 0.53).  Homogeneity for all nine trials is p = 0.246.  The Forest 
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plot favors probiotics preventing AAD.  This meta-analysis concluded there is evidence that 
probiotics provide protection against AAD.  These authors state that probiotics prevent AAD but 
it does not treat AAD. 
 Kale-Pradhan, Jassal & Wilhelm (2010) performed a meta-analysis of Lactobacillus in 
both pediatric and adult patients.  They looked at Lactobacillus as monotherapy for the 
prevention of AAD.  They analyzed ten RCT but this paper focused on the results for the adults, 
which are reported separately.  The risk reduction for the adults is reported as 0.24 (95% CI, 0.08 
– 0.75) using Mantel-Haenszel calculation.  Heterogeneity was well controlled Tau2 = 1.41; Chi2 
= 30.19; df = 5 (p< 0.0001), I2 = 83%.  The overall Z score was reported as 2.46 (p = 0.01).  A 
Forest plot showed Lactobacillus does prevent AAD in adults.  They reported a potential 
publication bias as the funnel plot graph is asymmetric owing to one of the adult studies had a 
very small n.  They also report the dose of Lactobacillus ranges from 2 x 109 – 4 x 1010 colony 
forming units (CFU).  It is of interest to note that the pediatric arm of this meta-analysis did not 
reach statistical significance.  This study concludes that Lactobacillus monotherapy prevented 
AAD in the adult population. 
 McFarland (2010) presents a systematic review and meta-analysis of S. boulardii in adult 
patients.  McFarland looked at multiple disease states but this paper concentrated on the meta-
analysis for AAD contained in her review.  The author reported on ten RCT in adults using S. 
boulardii as monotherapy.  The Forest plot favors S. boulardii as preventing AAD.  This analysis 
showed a pooled relative risk of 0.47 (95% CI, 0.35 - 0.63, p < 0.001).  The author reported that 
heterogeneity was well controlled X2 = 10.8, p = 0.29.  The author also reported no publication 
bias was found either in Begg’s test (p = 0.93) or the funnel plot.  The investigator also reported 
that the number needed to treat with S. boulardii to prevent on case of AAD was 10.2.  An 
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overall Z score was not reported.  This study reported that the use of S. boulardii monotherapy is 
effective in preventing AAD.  This was pooled data of both inpatient and outpatient so no 
specific conclusion can be drawn regarding adult outpatient data.   
 Sazawal, et al (2006) performed a meta-analysis that evaluated the use of probiotics in all 
types of acute diarrhea; AAD was a subset that was reported separately.  The inclusion criteria 
for this analysis looked at RCT that were masked and placebo controlled.  For inclusion the 
study design is an experimental arm and a control arm that “differed only by the provision of a 
probiotic and in which the risk of acute diarrhea in each arm was presented,” (Sazawal, et al, 
2006, p. 374).  Articles published in both English and French were considered for inclusion by 
the authors.  They reported on 16 articles that yielded 19 separate AAD studies, one of the 
articles had two arms and another had three arms to the study.  Ten of the articles focused on 
adults and six on children.  The risk reduction was reported as 52% (95% CI, 0.35 – 0.65) with a 
p = 0.001, for all ages.  Heterogeneity test was reported as I2 = 53% (95% CI, 40-68).  The Forest 
Plot is not reported for AAD.  Overall, probiotics were shown to have a protective effect.  When 
community is the setting probiotics were still shown favorably but not as strong as the overall 
effect 0.94 (95% CI, 0.87 – 1.02).  The pooled n of the community is 1927; adults and children 
cannot be teased out since one of the community studies did not report the age groups separately.  
This study also reports a number needed to treat as being for every four adults receiving 
probiotics one will have acute diarrhea prevented.  This study correctly comments that very few 
trials have been carried out in the community regarding probiotics and the prevention of 
diarrhea. Those that have been done looked at travelers’ diarrhea or infectious diarrhea, none in 
this analysis focused on AAD.  These authors found that effect size of probiotic prevention of 
AAD type was the highest compared to all other types of acute diarrhea. 
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 Szajewska & Mrukowicz (2005) analyzed five RCT that evaluated S. boulardii for the 
prevention of AAD.  They used STATSDIRECT software and QUOROM standards to analyze 
the data.  The total n is 1076.  They reported a risk ratio of 0.43 (95% CI, 0.23-0.78).  This 
analysis included both children and adults.  Unfortunately, the age groups are not reported 
separately.  The Forest Plot does favor the use of probiotics to prevent AAD.  By excluding one 
of the trials they were able to achieve homogeneity (X2 =2.9; p = 0.4) and maintain significance, 
0.33 (95% CI, 0.22-0.5).  They report no publication bias or small sample bias.  This analysis 
reported on five studies and was the smallest of the meta-analyses.  They report the number 
needed to treat to prevent AAD is ten.  This analysis supports the conclusion that S. boulardii 
reduces the risk of AAD. 
 Armuzzi, et al. (2001) report on a RCT in which they gave outpatient adults probiotics 
during a specific antibiotic treatment.  The investigators randomized sixty healthy asymptomatic 
Helicobactor pylori positive adults to probiotic and placebo.  They used a preparation of 
Lactobacillus GG (6 x 109 CFU) for 14 days; during the week of treatment and the week after 
treatment.  The treatment was seven days of raberprazole 20 mg twice a day, clarithromycin 500 
mg twice a day and tinidazole 500 mg twice a day.  The probiotic was given twice a day one and 
half hours after the administration of the antibiotic.  Of all of the side effects of antibiotic use 
included in the study only diarrhea is significant between the two groups (p=0.026).  They 
reported a difference in diarrhea rates: placebo being 26.6% versus probiotic 3.3% during the 
treatment week.  During week two the placebo group had 10% diarrhea and the probiotic group 
3.3% diarrhea.  The diarrhea was self reported as mild for all participants, which in the context of 
the study is defined as ‘observed by could be disregarded’.  It should also be noted that the study 
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participants were all medical personal (physicians, nurses, biologists, or administrators).  This 
study shows that probiotics are effective in reducing AAD in the outpatient adult population. 
 In summary, the seven meta-analyses and one RCT all report a reduction of diarrhea 
when probiotics are used to prevent AAD.  They all agree that several different probiotics are 
safe to use in a wide variety of diagnoses, antibiotics, patient populations and settings.  What is 
lacking are studies done in the adult outpatient population.  The limitations of these analyses are 
there is overlap of the studies contained across the meta-analysis, there is no agreement on which 
probiotic is the most efficacious, and there is no agreement on dose.  
Prescriber Attitude, Knowledge and Habits 
There is no research regarding what is current practice in the primary care setting of 
probiotic prescribing, in the United States.  This may be related to provider lack of education of 
efficacy and safety of probiotics.  This may also be related to provider attitude to alternative 
medication use.  The next section illustrates prescriber attitude and knowledge of probiotic use. 
 Hermosilla (2009) looked at attitude and knowledge of prescribers towards probiotics in 
an intensive care setting.  The author found that an educational offering increased both physician 
(MD) and nurse knowledge and attitudes.  However, in the large intensive care setting staff was 
not stable and the effect did not appear to be sustained.  The prescriber group consisted of MDs 
only.  The author reports a two fold increase in probiotic prescriptions after the educational 
offering.  Pre-education session showed 2% (n=2) of the patients receiving antibiotics were 
prescribed a probiotic.  After the educational session 5% (n=4) were prescribed a probiotic.  
While this is an increase in the prescribing of probiotics it is a small increase, Hermosilla (2009) 
reports a p value of 0.003. 
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 Nichols, Grob, and Roche (2005) sent a web-based questionnaire to outpatient primary 
care providers in Surrey, England.  They reported a 16.6% response rate (n=99).  Of the 
responders, they found 54% of providers have advised patients on the value of taking probiotics.  
Seventy-three percent reported they believed probiotics reduce the incidence of diarrhea.  This 
study was not specific to AAD.   
 In summary, these findings show a lack of comprehensive information describing 
provider attitude, knowledge and prescribing habits toward probiotics, the studies emphasize the 
importance of educating providers on the pathophysiology, efficacy and safety of probiotics in 
the prevention of AAD.   
Theoretical Framework 
The Stetler Model of Research Utilization to Facilitate Evidence-Based practice was used 
to frame this study (Gawlinski & Rutledge, 2008; Snyder, Facchiano, & Brewer, 2011; Stetler, 
2001).  This model supports implementation of practice changes at both the individual and the 
organizational levels (Gawlinski & Rutledge, 2008; Stetler, 2001).  Stetler (2001, p. 274) states 
in her first assumption that the “formal organization may or may not be involved in an 
individual’s utilization of research.”  This model is also well suited to the provider who has the 
ability to evaluate knowledge within their own field of expertise and to evaluate if that evidence 
supports a practice change (Snyder, Facchiano, & Brewer, 2011).  At this time the primary care 
practice, where the implementation occurred, has no formal process for the integration of 
evidence-based practice (EBP).  However, they do have an organizational roadmap for defining 
initiatives using five pillars: service excellence, quality, people, growth, and financial strength.  
The integration of EBP supports the quality pillar of the balanced scorecard.  The quality pillar is 
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defined as “insuring that an infrastructure is in place to drive clinical and service excellence.”  
The implementation of EBP would not only support clinical excellence within this pillar it would 
provide a process for the implementation of future EBP projects. 
 Stetler’s (2001) model has five phases: preparation, validation, comparative 
evaluation/decision making, translation/application, and evaluation.  The following describes the 
use of Stetler’s model in this project.  The preparation phase was started as part of a 
demonstration project at a local SNF, using frail elderly patients.  This project leads to inquiring 
if the same outcomes could be applied in the outpatient adult setting.  The literature review done 
for the proposed study focused on meta-analyses, accepted as Level I evidence.  As indicated 
earlier there are no published evidence-based practice guidelines available.  Based on an analysis 
of the studies reviewed a practice protocol can be recommended.  A randomized controlled trial 
was part of the literature review as it best matched the population and setting of the proposed 
study.  The researcher chose to use meta-analysis as the basis of the literature review as the key 
stakeholder is a MD who values Level 1 evidence.  The use of Level 1 evidence provides a 
strong support for the proposed educational intervention.   
Phase II, Validation, was done as a critique of the meta-analyses and one RCT; these 
showed that the findings were supportive of the use of probiotics in preventing AAD.  A 
conclusion of the literature review found several areas that needed to be specified in the present 
study such as provider attitude and knowledge toward the use of probiotics to prevent AAD.  In 
an unpublished study of a quality improvement project done in a long term care facility, the 
implementation of concurrent use of antibiotics and probiotics has reduced the incidence of AAD 
in this population to zero. This project was developed in response to an increase of diarrhea in 
the facility population.  A literature review was done and a protocol was presented to the medical 
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staff for approval.  After approval by the medical staff it was implemented.  After approximately 
18 months the protocol was reviewed, a cost analysis was performed and the protocol was 
streamlined.  This protocol continues to be successfully used at the facility.  The above issues 
impact on the practice utilization as described in Snyder, Facchiano, & Brewer (2011). 
Comparative evaluation and decision making, Phase III, requires the synthesized 
information found in Phase II be applicable to the practice setting for a change in practice.  The 
meta-analyses reviewed support the use of prophylactic probiotic use.  There are barriers to the 
applicability of this information in the current practice setting.  These barriers include provider 
attitude and knowledge.  The proposed study has a good fit in the outpatient setting.  The 
research study is feasible to complete in the proposed setting, substantiates the current evidence 
and impact to current practice. 
Phase IV, translation and application, provided an insight into what the current state of 
practice and what barriers must be overcome for full application.  The proposed study offered 
insight into the number of probiotics currently being recommended and this is correlated with the 
same provider groups’ knowledge and attitude towards the use of probiotics. 
Evaluation, Phase V of Stetlers’ model was done when the data is collected and analyzed 
from the study.  Refinements were made in the proposed probiotics protocol.  Further research is 
suggested from the data analysis of the three different purposes of the study. 
Project Plan 
Project Design 
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This project design used two different methods.  The first design was a description of the 
current use of probiotics in a large corporate primary care and urgent care practice group.  The 
second project design was a pre and post test of probiotic knowledge and attitude of provider.  
These surveys were given before and after an educational intervention presenting a literature 
review supporting the use of probiotics to prevent AAD.  
The descriptive project looked at the number of antibiotics and probiotics prescribed by 
this group at two points in time.  The choosing of the time frame is arbitrary.  This group of 
providers uses the Allscripts® electronic medical record which includes the recording of 
prescribed medications.  A random week one month prior to the educational intervention was 
selected; a data report asked how many antibiotics have been prescribed during a seven day time 
frame.  There was no restriction on the drug class of antibiotic or infective process.  It was 
presumed that all prescribed antibiotics are appropriate to the infective process.  This descriptive 
number was then paired with the descriptive number of how many probiotics were prescribed 
during this same seven day time frame.  This data was analyzed by provider, MD, NP, and PA.  
This data provided information on the prescribing habits of primary care providers without 
intrusion by the researcher.  This information is valuable in that are few reports of primary care 
prescribing habits with descriptive statistics.  The disadvantage of this study design is the 
inability to provide generalization to any other group. 
A pre and post test design utilizing a convenience sample of primary care providers who 
prescribe antibiotics was used.  The inclusion criterion was all providers; MDs, NPs and PAs 
working at the same large practice group as described above.  An email was sent to all providers 
in the group introducing them to the project.  Basic demographic information including names 
were obtained.  Only the researcher has access to the names of participants.  The provider names 
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were converted to a numeric label during data entry.  The participant label was used to compare 
the pre and post test results for an individual. 
The pre-intervention survey was provided before the educational intervention was 
presented.  The intervention is a power point presentation discussing evidence recommending the 
use of probiotics in the prevention of AAD (see Appendix 1 for the protocol and Appendix 7 for 
the educational intervention).  A post intervention survey was provided just after the educational 
intervention presentation.  It is understood that this design might have an effect on the 
prescribing habits of those who participate by virtue of presenting the information.  It is 
unknown if the effect is long lasting.  
 The information was requested from the IT department.  A random week in February 
2012 was chosen.  This represented approximately one month prior to the start of the educational 
intervention.  The second data run was requested a week after the last educational intervention.  
The original plan was to wait a month after all interventions were completed but time constraints 
did not allow for the time to wait.  The data came in an excel spreadsheet.   The data was coded 
and loaded into IBM SPSS Statistics 20 software.   
 The second part of the study was an educational intervention with a pre and post test 
questionnaire.  This was originally to be done at a staff meeting where all of the providers would 
be in attendance.  Unfortunately, due to scheduling and time constraints this was not possible.  
Instead the educational intervention was provided at the individual provider offices in small 
groups.  The presentation was kept consistent and providers were able to ask questions.  The 
providers were assigned a number and all information was entered into the IBM SPSS Statistics 
20 software system on the day it was obtained.   
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Sample 
The study subjects were the 70 providers at a large multi-site primary care group.  These 
providers consist of MDs, NPs and PAs.  The MDs are both family practice and internal 
medicine specialties.  The NPs are both adult and family specialties.  The PAs also practice in 
primary care and urgent care specialties.  With a sample size of n=70, small effect size (0.3) 
determined by Cohen’s convention, and a=0.05, the study has a minimum power of 0.6967 when 
using Lenth’s website for calculation for a paired t-test (Lenth, 2006-9).  Using the same sample 
size, alpha, and small effect size determined by Cohen’s convention when using a table cited in 
Munro, (2005). 
 The original sample was 70 providers, MD, NP, and PA.  These providers are a part of a 
large multi-site primary care group.  The group is located in central and eastern Connecticut.  
The data received from the IT department revealed 71 providers had prescribed antibiotics in the 
selected week prior to the educational intervention.  When the data was received from the IT 
department after all of the educational interventions were complete there were 73 providers who 
had prescribed antibiotics.  Of the providers who prescribed antibiotics 27 completed the project.  
This represents only 37.5% of the available providers.  This was significantly below the project 
goal of 50%.  The greatest percentage of participants were the MDs at 15 participants, then the 
NPs at 8 participants and finally the PAs at 4 participants, please see Table 1.   
Project Site 
These providers are part of a large multi-site corporate practice consisting of both 
primary care and urgent care.  The researcher is a provider at one of the primary care sites.  
These offices are located in central and eastern Connecticut.  The researcher is affiliated with one 
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of the offices located in eastern Connecticut.  This provider group is affiliated with a tertiary 
acute care center as part of an Accountable Care Organization (ACO).   They serve a diverse 
population of patients, within urban, suburban and rural areas.  They accept all major 
commercial insurance plans and Medicare but they do not accept new patients with Medicaid.  
This practice group is being used as a convenience to the researcher; as she has access to the 
providers and the data.  There is a corporate culture of innovation and the CEO is supportive of 
this clinical research project.  The formal letter of support from Dr. Kent Stahl is found in 
Appendix 4.  Currently it is unknown as to how many antibiotics are prescribed and how many 
probiotics are being recommended in this provider group.   
Educational Intervention 
This project presented an evidence based protocol abstracted from the current literature 
review.  This protocol, found in Appendix 1, was developed by the researcher.  The protocol was 
sent to the local Gastroenterologist, an APRN with a specialty in Gastroenterology and Infectious 
Disease specialist for review.  These providers gave feedback to the protocol and it was 
incorporated into the final protocol.  The protocol was introduced to the providers during the 
educational intervention.  The educational intervention consisted of: 
• a review of translational research 
• a review of AAD,  
• gut pathophysiology,  
• antibiotic disturbance of gut flora,  
• overview of current literature 
• presentation of the proposed protocol found in Appendix 1. 
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 The education intervention consisted of a PowerPoint presentation describing several 
meta-analyses and randomized control trials supporting the use of probiotics for the prevention 
of AAD.  The PowerPoint presentation can be found in Appendix 7.  A protocol for the use of 
the probiotics in the outpatient adult setting was presented and discussed during the intervention.  
The providers attending were given a copy of the protocol, see Appendix 1.  The providers were 
also given a handout for patients explaining probiotic use, see Appendix 5.  There was positive 
feedback related to both the information presented and the handouts.  Providers were encouraged 
to implement the protocol.  The interventions went very well, the MDs were respectful.  The 
researcher was not made to feel that the information was not valuable because of my professional 
title. 
Instruments 
Prior to the intervention a questionnaire was used to evaluate the office provider’s 
attitude and knowledge of probiotics use.  The questionnaire that was used was developed and 
tested by Nichols, Grob and Roche (2005), there is no identifying name for the questionnaire.  
They developed the questionnaire, which consists of 20 items, to look at multiple reasons for 
using probiotics.  For the purposes of this study only the first four questions were used as a pre 
and post test for this project.  The original questions developed and used by Nichols, Grob, and 
Roche (2009) is reproduced below.   The first 4 questions and the last 7 questions are yes or no 
answers.  The middle 6 questions responses are never, occasionally or frequently. 
Nichols, Grob and Roche Provider Probiotic Questionnaire (2009): 
Please answer yes or no for the following questions: 
1.  Which of the following apply to your advice to patient regarding probiotics: 
A. I know of no reason to advise patients to take probiotics 
B. Probiotic usage may be valid but I have not advised patients on this 
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C. I have advised patients on the value of probiotics 
2. Probiotics decrease the incidence of diarrhea 
3. Probiotics decrease the risk of thrush 
Some of us are ‘trigger happy’ when it comes to prescribing antibiotics, but there is also 
the danger of failing to prescribe an antibiotic when an antibiotic is genuinely needed.  
Assuming you decide than an antibiotic is necessary, in which of these conditions have 
you advised a patient to take a probiotic with and/or after the course of antibiotics?  
Please answer never, occasionally, or frequently for the following questions:  
4. Probiotics give a boost to host immunity 
5. Children with acute suppurative otitis media 
6. Health young patients with acute bronchitis 
7. Elderly patients with pneumonia 
8. Recurrent acute cystitis 
9. Severe painful dental abscess 
10. Diverticulitis with pyrexia 
Other conditions have been found to respond to probiotics to a greater or lesser degree 
and probiotics have been suggested as part of a preventive strategy for some conditions.  
Have you advised patients to take probiotics for any of the following?  Please answer yes 
or no for the following questions: 
11. Severe eczema 
12. Recurrent vaginal thrush 
13. Crohn’s disease 
14. Ulcerative colitis 
15. To reduce the risk of bladder and bowel cancer 
16. To reduce the risk of coronary artery disease 
17. An infant recovering from viral gastroenteritis 
Questions five through seventeen do not pertain to the proposed research project and therefore 
was not used for this project.  The proposed questionnaire is attached in Appendix 2. 
Permission was received from Dr. John Nichols and his co-author Dr. Paul Grob to use 
the questionnaire they developed (Nichols, Grob and Roche, 2009).  Permission was granted in 
the form of an email dated August 10, 2011, see Appendix 6.  The original questionnaire was 
designed to look at many other disease processes that probiotics may be helpful.  As stated above 
only the first four questions pertained to this project.  Question three was changed due to 
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terminology confusion between the United States and England.  They used the term “thrush” 
meaning a vaginal yeast infection.  The term “thrush” was changed for the purposes of this 
project.  This project used the statement: “vaginitis due to yeast.”  Thrush has a different 
connotation for United States providers. 
Procedure 
Institutional Review Board (IRB) approval was obtained from University of 
Massachusetts after a lengthy process.   My protocol was approved March 1, 2012.  This set my 
project timeline back by eight weeks as data collection had been slated to start the beginning of 
January.  Formal approval from Dr. Kent Stahl was obtained on February 13, 2012, see 
Appendix 4.  The project was introduced at the March Medical Directors meeting by Dr. Kent 
Stahl.   An email was sent to the providers introducing the research project.  The initial email 
included an overview of the research project and what participation requires.  The email 
addresses of the providers were obtained from the shared email group of which the researcher is 
a part.  An email was sent to all 71 providers to introduce the project.  This email consisted of an 
outline of the project as well as the IRB information.  A separate email was sent to all of the 
medical directors requesting to be included in a staff meeting for the purposes of presenting my 
educational intervention. 
The educational intervention was accomplished by visiting individual office provider 
groups and presenting at their monthly provider staff meeting.  Six offices were visited between 
the March 14, 2012 and April 15, 2012.  This was an average of 4.5 providers at each 
presentation.  One office had only one provider available and the others had four or five 
providers available.  I was also able to capture three more providers after a meeting for the NPs 
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and PAs.  A summary of the demographics of the providers who participated is found in Tables 
1-4. 
Data Collection 
The first of data collection for this project was a data set from Electronic Medical Record 
(EMR) regarding the current probiotic prescribing habits of providers before and after the 
intervention of the educational program. The data requested was limited to adults, 18 years and 
older.  An arbitrary week was selected prior to the educational intervention. February 5-11, 2012  
A second arbitrary week was selected after the educational intervention, April 22-28, 2012.  This 
was accomplished by filling out an “Analytics Report Request,” a reproduction of this form is 
found in Appendix 3.  The form was submitted to the IT team.  The data set parameters that were 
requested from the Information Technology (IT) team: the total number of antibiotics prescribed 
and total number of probiotics prescribed during that week for all patients older than 28 years, 
any provider, any antibiotic, any probiotic, any diagnosis.  Since the data is to determine 
provider prescribing habits no patient identifier or patient demographics were requested.  The 
same process was used for both weeks that the data set was requested. 
 The EMR used by the providers in the study was Allscripts®.  This EMR can record both 
medications requiring prescriptions as well as over the counter medications.  This information is 
stored in the medications section of the EMR and is to be reconciled at every visit.  
Reconciliation is the means by which the provider determines that the current list of medications 
is accurate.  One of the drawbacks of this study is that there is no way of knowing why the 
probiotic is not documented in the EMR; not prescribed or not documented.  Whether the patient 
actually follows through with taking the probiotic is outside the scope of this study. 
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Prior to the educational intervention the providers filled out a one page survey that 
included both the demographics and the short questionnaire.  The questionnaire consisted of 
demographic data and four questions.  The four questions are listed in Appendix 2.  The 
demographics included: 
• Name (which is only used for matching the tests) 
• Provider type: MD, NP, or PA 
• Gender: Male or Female 
• Age: 20-29, 30-39, 40-49, 50-59, 60-69, 70 or older 
• Educational level: certificate, masters, MD or PhD 
The surveys from each provider were entered into an IBM SPSS Statistics 20 software 
database for analysis. 
Data Analysis 
The analysis of the information collected from the Allscripts® EMR regarding current 
prescribing habits was done with descriptive statistics.  This provides a snapshot of current 
clinical practice of the providers in this primary care group.  This data are numbers for the entire 
provider group and are broken down by individual provider.  This same data set was requested 
approximately two weeks after the last educational intervention.  A comparison of the 
prescribing of both antibiotics and probiotics using descriptive statistics was done.  
The data gathered from the questionnaire was analyzed by both descriptive statistics and 
a paired t-test.  A paired t-test was utilized because the survey was identified by the provider 
name.  The raw data with the name was only be seen by the researcher.  The paired t-test was 
analyzed using IBM SPSS Statistics 20 software.  The descriptive statistics were used to 
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compare the different provider groups, MD and NP, to see if there are differences in attitude and 
knowledge after the educational intervention and presentation of the clinical practice protocol.  
The PA information was only used in the summary data and was not compared to the other 
providers since there a small number of PA participants (n=4). 
Barrier to Project Implementation 
This study is only looking at provider attitudes, knowledge and prescribing habits.  One 
drawback of this study is the outcome of diarrhea in the patients was not determined.  The 
questionnaire is only 4 questions long and this should not be a burden.  The educational 
intervention was delivered in person.  It is anticipated that due to the suggestion of a practice 
change by an NP to a largely MD group may create some resistance of implementation of this 
practice protocol.   
 The MDs did not voice any resistance to a practice change suggested by an NP.  This was 
a barrier that was anticipated but was not encountered during the study.  The response was 
positive from all the MDs.  I felt more resistance from the NPs and PAs and had difficulty 
getting them to stay and listen to the educational program.  It is unknown as to why the NPs and 
PAs were resistant; this could be a false perception by the researcher.  The most challenging 
barrier was the reduced time line to provide the educational intervention to the providers.  The 
scheduling was difficult due to provider meetings being only once a month.  While the medical 
directors in each office were contacted directly, often it was the practice manager who scheduled 
the meeting.  The practice manager was not necessarily aware of the project and often it took 
several emails to schedule the intervention.   
Budgeting and Cost 
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 The cost of this project was very minimal.  Cost of the project is the time of the 
researcher.  The request for the EMR data carried no cost.  The questionnaire was created and 
printed on the researcher’s personal computer.  The expense of obtaining IBM SPSS Statistics 20 
software was less than expected, $44.94.  However, the cost of gas to drive to each office was 
much greater than anticipated.  The total mileage was 263 miles at 55.5 cents a mile comes to a 
total of $145.97.  The original budge was approximately $300.00 this project came under budget 
by $109.09.  These expenses were absorbed by the researcher. 
IRB Approval and Ethical Considerations 
 IRB approval from the University of Massachusetts, Amherst, was required as an 
expedited application as no patient identifying information is being collected.  The use of the 
EMR information is purely numerical, how many antibiotics prescribed and how many 
probiotics are prescribed at the same time.  The knowledge survey asked for a name and minimal 
demographic information on the providers.  Names and demographic information were kept 
confidential.  The results of the pre and post intervention survey have only been viewed by the 
researcher and researcher’s primary advisor.  The benefit to the providers was the participation in 
and educational offering on probiotics and the distribution of an evidence based practice 
protocol. 
 The University of Massachusetts IRB granted approval on March 1, 2012.  Approval for 
the provider group was granted by Dr. Kent Stahl on February 13, 2012.   
Time Line 
Task Deadline 
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Capstone project approval December 20, 2011 
UMass IRB approval December 30, 2011 
Hartford Medical Group (HMG) IRB approval December 30, 2011 
Contact each medical office at HMG to set up 
the educational session 
January 5, 2012 
Contact with HMG IT Department to request 
EMR data for the previous 7 days 
January 10, 2012 
Finalize the providers data set and analyze January 10, 2012   
Analyze the questionnaire  January 20, 2012 
Educational sessions with each office to start January 20, 2012 
Educational sessions with each office to 
conclude 
February 15, 2012 
Analyze provider questionnaire February 20, 2012 
Contact with HMG IT Department to request 
EMR data for the previous 7 days 
February 20, 2012 
Analyze and compare EMR data February 29, 2012 
 
Results 
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Data Analysis  
EMR Findings 
The analysis of the information collected from the Allscripts® EMR regarding current 
prescribing habits provides a snapshot of current clinical practice of the providers in this primary 
care group.  The information provided showed that 71 providers were listed as prescribers in this 
data set.  In the first week of the data collection 764 antibiotics were prescribed in the one week 
period between the dates of February 5, 2012 to February 11, 2012.  There were 4477 patient 
visit for these same 71 providers during this same time frame.  This would be a prescribing rate 
for this group of 171 antibiotics per 1000 patient visits.  Of the 71 providers prescribing 
antibiotics only two providers recorded recommending probiotics to five different patients.  Both 
of these providers were NPs.  This translates to five patients who have a probiotics recorded in 
the EMR at the same time as an antibiotic.  For the period of April 22, 2012 to April 28, 2012 
there were 73 providers prescribing and 504 antibiotics prescribed.  Three providers prescribed 
probiotics to three different patients.  These three providers were two MDs and one NP, the NP 
was a different NP from the two NP prescribers in the first data set.  This is a 50% increase in the 
number of providers prescribing probiotics but a decrease in the number of patients.  This may 
be explained by the decrease in the number of antibiotics prescribed during the second time 
frame. 
Comparison of Prescribing Habits of MDs and NPs 
A comparison of the prescribing habits of MD, NP and PA was also analyzed.  For the 
week of February 5, 2012 to February 11, 2012, the prescribing habits are not different across the 
provider types (F=2.217, p=0.110).  For the week of April 22, 2012 to April 28, 2012, the 
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prescribing habits across the provider types are had no significant difference (F=1.268, p=0.261).  
This is consistent with national prescribing habits between provider types (Gonzales, Barrett, 
Crane & Steiner, 1998, Ladd, 2005, & Roumie, et. al, 2005) 
Provider Attitude toward Probiotics 
The data reveals that 21 of the 27 (77.8 %) providers have advised probiotics prior to 
attending the educational presentation.  After the presentation 24 (88.9%) providers stated that 
probiotics would be advised.  Only two of the providers felt that probiotics may be valid but that 
they would not advise the use of these supplements.  None of the providers chose the option, “I 
know of no reason to advise patients to take probiotics.”  
Provider Knowledge of Probiotics 
 Knowledge questions two, three and four were combined to create a knowledge score.  
The percent of providers aware of probiotic use pretest was 58.02% the posttest percentage 
increased to 75.54%, see Table 8.  This is a 17.52% increase in probiotic knowledge after the 
educational intervention.  There was a significant difference (p=0.001) in the scores for pre-
knowledge (M = 4.92, SD = 1.521) and post knowledge (M = 3.81, SD = 1.021).  The correlation 
between the two measures was 0.274 (p=0.176).  
Difference between MD and NP in Attitude and Knowledge 
The paired t-test showed no significant difference in attitude towards the use of probiotics 
between the MDs (pretest: n=15, mean=2.87, SD=0.352 and posttest: n=15, mean=2.87, 
SD=0.352) and NPs (pretest: n=8, mean 2.88, SD=3.54 and posttest: n=8, mean=3.00, SD=0.000)  
For question one the pretest showed equal variances (F=0.012, p=0.957) and the posttest for 
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question one also showed equal variances, (F=6.278, p=0.164).  The knowledge score showed a 
significant difference between MDs pretest (n=15, mean 5.2667, SD=1.16292) and NPs pretest 
(n=8, mean=3.7500, SD=1.03510).  Again, there was a significant difference between MD 
posttest (n=15, mean=4.2000, SD=1.08233) and NP posttest (n=8, mean=3.0000, SD=0.0000).  
The paired t-test for the pretest knowledge score also showed a significant difference between 
MDs and NPs (F(21)=0.034, p=0.006).  The paired t-test for the posttest knowledge score 
showed a significant difference between the MDs and NPs scores (F(21)=59.345, p=0.005). 
Discussion 
The purpose of this study was to evaluate the attitude and knowledge regarding the use of 
probiotics to prevent AAD in the outpatient adult setting.  The results show that MDs and NPs 
have a positive attitude towards the use of probiotics. They have advised their patients on the 
value of these supplements.  The results also show that MDs and NPs increased their knowledge 
of probiotics due to the educational intervention.  However, it was found that NPs had a greater 
increase in their knowledge scores as compared to MDs.  
 The goal of introducing an evidence based protocol was accomplished.  The protocol was 
presented to the providers and they were encouraged to use it.  There was positive feedback 
during the educational sessions for the protocol.  The providers indicated that the handout that 
described the protocol was helpful especially since it contained specific recommendations on 
dosing and length of treatment.  Dr. Kent Stahl supported the use of this protocol within our 
primary care and urgent care practice.   
 The third purpose of this study was to evaluate the providers’ use of probiotics as 
documented in the EMR.  The initial data revealed that while providers have a positive attitude 
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towards probiotics and recommend probiotics they are not recording this in the EMR.  After the 
education intervention the probiotics that were recorded in the EMR increased by 50%.  There 
were two different prescribing providers both NPs who prescribed probiotics prior to the 
educational intervention.  After the educational intervention there were three different providers 
that prescribed probiotics, two MDs and one NP.  The extra step of recording the probiotic in the 
EMR is problematic.  It is actually five extra mouse clicks to record another medication in the 
EMR, many providers feel overwhelmed with the amount of information they are required to 
record already.  This has been a common complaint voiced at provider meetings within this 
group.  In future studies with this group, if the providers could be incentivized to record the 
probiotics this might improve recording outcomes.  If the providers could be shown a short cut 
within the EMR system that decreased the amount of mouse clicks to record this 
recommendation this might also improve the recording of probiotic recommendations. 
 When the knowledge scores were evaluated NPs showed a greater beginning knowledge 
of probiotic use as compared to MD.  The NPs also increased their knowledge to a greater degree 
than MDs in the posttest.    
 The data also supported the assertion that there is no difference in the prescribing habits 
of MDs and NPs.  This can be looked at two different ways.  As a negative it could be interpreted 
as NPs should prescribe fewer antibiotics because they should be encouraging more self care 
interventions and utilize an antibiotic as the last resort.  As a positive it supports the notion that 
NP practice is no different than MD practice.  This group’s antibiotic prescribing habits of 171 
per 1000 is well below the national average of 302-304 per 1000 reported by Roumie, et al., 
(2005).  
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 The goals of this project were not all met.  The project fell short on the goal of 50% 
participation from the 70 providers’ eligible, only 38% were recruited.  This was due to the late 
approval from the IRB.  The evidence-based protocol for the use of probiotics to prevent AAD 
was created and presented in the adult outpatient setting.  The protocol appears to have been well 
received by the providers who attended the educational interventions.  The interventions went 
smoothly and care was taken to present the information in the same way at each office.  The goal 
of documenting and analyzing current antibiotic and probiotic prescribing habits was met.  
However, since probiotics are over the counter supplements this is really measuring the providers 
documentation of the probiotic in the EMR.  There is no way to know if the patient actually 
followed this recommendation. 
 A limitation of this study were that the small number of providers that participated in the 
educational intervention.  This study looked at the prescribing providers of a primary care and 
urgent care group; these results cannot be generalized to other provider populations.  This study 
will be continued until the participants’ number over 50.  There are already three more offices 
scheduled to have the educational program in May and June.  
 In conclusion this study showed that primary care providers have a positive attitude 
towards the use of probiotics.  It also showed that providers increased their knowledge of 
probiotic use as a result of an educational intervention.  The actual prescribing rate of probiotics 
as recorded in the EMR was slightly higher after the educational intervention; however due to 
the small number of participants it may not be attributable to the educational intervention.  It is 
proposed that actual recommendation of probiotics is higher but it is just not recorded in the 
EMR.   
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Future Directions 
 Further research is needed on the use of probiotics.  The implementation of the proposed 
protocol could be one future study.  Further research is needed on both the dosing of probiotics 
as well as the timing of probiotics.  There is little research confirming the dosing of probiotics at 
five billion colony forming units.  There is also little research specifically focused on when the 
probiotic should be given in relation to the antibiotic.  The patients in the outpatient adult setting 
have not been well represented in current research.  A qualitative study that addresses the patient 
experience with the use of probiotics would advance the body of literature for adults. 
 The abstract for this paper was submitted to American Association of Nurse Practitioners 
Foundation for a grant to continue research in this area.  The grant is for best practices in the use 
of nutritional supplements.  The dealing for submission is April 30, 2012 and the award 
presentation will be the 27th Annual American Association of Nurse Practitioners National 
Conference in Orlando, Florida.   
Plans for Dissemination 
 The pathophysiology and the demonstration quality initiative that inspired this project 
have already been presented twice.  The quality initiative has been presented in poster form at 
three different nursing conferences: the national DNP conference in San Diego California 
September 2010, Connecticut Advanced Practice Registered Nurse Society’s annual conference 
May 2011, and CT Nursing Research Alliance Conference on 10/14/11.  The poster received 
third place at the CT Nursing Research Alliance Conference and honorable mention at the 
Connecticut Advanced Practice Registered Nurse Society’s conference.  The pathophysiology 
and the quality initiative were presented at this year’s Connecticut Advanced Practice Registered 
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Nurse Society’s annual conference as a session choice.  The results of this project are to be 
presented at Windham Community Memorial Hospital at Grand Rounds, to be scheduled in June. 
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Table 1 
Percent of Providers by Title 
Professional Title Frequency Percent 
MD 15 55.6% 
NP 8 29.6% 
PA 4 14.8% 
Total 27 100% 
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Table 2 
Percent of Providers by Gender 
Gender Frequency Percent 
Male 10 37.0% 
Female 17 63.0% 
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Table 3 
Percent of Providers by Age  
Age Range Frequency Percent 
20-29 0 0% 
30-39 7 25.9% 
40-49 8 29.6% 
50-59 7 25.9% 
60-69 3 11.1% 
70+ 0 0% 
Missing 2 7.4% 
Total 27 100% 
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Table 4 
Percent of Providers by Educational Preparation 
Educational Level Frequency Percent 
Certificate 1 3.7% 
Masters 10 37.0% 
MD 15 55.6% 
DNP 0 00.0% 
Missing 1 3.7% 
Total 27 100% 
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Table 5 
Question 1 Responses 
Questions 1 
Which of the following statement apply to your advice to 
patient regarding probiotics: 
Pre-Test Post-Test 
a. I know of no reason to advise patients to take 
probiotics 
0 0 
b. Probiotic usage may be valid but I have not 
advised my patients on these supplements 
5 2 
c. I have advised patients on the value of taking 
probiotics 
21 24 
Missing 1 1 
Total 27 27 
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Table 6 
Question 2 Responses 
Questions 2 
Probiotics decrease the incidence of diarrhea 
Pre-Test Post-Test 
Yes 25 26 
No 0 0 
Don’t know 1 0 
Missing 1 1 
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Table 7 
Question 3 Responses 
 
Questions 3 
Probiotics decrease the risk of vaginitis due to yeast 
Pre-Test Post-Test 
Yes 15 20 
No 4 4 
Don’t know 7 2 
Missing 1 1 
Total 27 27 
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Table 8 
Question 4 Responses 
 
Questions 4 
Probiotics give a boost to immunity 
Pre-Test Post-Test 
Yes 7 16 
No 8 7 
Don’t know 11 3 
Missing 1 1 
Total 27 27 
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Table 9 
Combined Knowledge Score 
 
Questions 2, 3, & 4 
2.  Probiotics decrease the incidence of 
diarrhea 
3.  Probiotics decrease the risk of vaginitis 
due to yeast 





Yes 47 58.02% 62 75.54% 
No 12 14.81% 11 13.58% 
Don’t know 19 23.46% 5 6.17% 
Missing 3 3.7% 3 3.7% 
Total 81 100% 81 100% 
Percent columns may not equal 100 due to rounding. 
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Appendix 1: Evidence-Based Protocol Describing the Use of Probiotics in the Adult 
Outpatient Population. 
When an antibiotic is prescribed for any condition the following guidelines can be taken into 
consideration when also prescribing a probiotic. 
Strain: Lactobacillus, S. boulardii, Bifdobacterium are the most studied probiotics. (Avadhani & 
Miley, 2011, Cremonini, et al, 2002, Edwards-Marshall, 2011, Hickson, et al, 2007, Hunter, 
2004, Rohde, Bartolini, & Jones, 2009, Santosa, Farnworth, & Jones, 2006, Vrabie & Aberra, 
2009, & Weichselbaum, 2009, Williams, 2010) .Culturelle, Align, Florastor or generic 
equivalent will be recommended since these OTC products contain one of the above mentioned 
probiotics.   
Dose:  1 million to 100 billion CFUs QD to BID. (Avadhani & Miley, 2011, Cremonini, et al, 
2002, Fox & Dang, 2004, Hickson, et al, 2007, Rohde, Bartolini, & Jones, 20091 & Santosa, 
Farnworth, & Jones, 2006) 
Dose Timing:  At least 2 hours from the dose of antibiotic. (Williams, 2010) 
Therapy Duration: At least during the antibiotic treatment course and up to 6 weeks after 
completion.  The average is 7-14 days. (Edwards-Marshall, 2011, Cremonini, et al, 2002 & 
Vrabie & Aberra, 2009) 
Contraindications: S. boulardii should not be given with antifungals. (Williams, 2010) 
Safety: Probiotics are generally considered safe. (Hickson, et al, 2007, Rulis, 2002 
&Venugopalan, Shriner, Wong-Beringer, 2010) 
Risk Factors for Sepsis: Immune compromised individuals (including debilitated state or 
malignancy) and Premature Infants are at risk for sepsis.  Minor risk factors include: central 
venous catheter, impaired intestinal epithelial barrier, administering probiotic by jejunostomy, 
broad spectrum antibiotic to which the probiotic is resistant, probiotics with high mucosal 
adhesions, use of Lactobacillius and cardiac valvular disease.  The presence of one major risk 
factor and two or more minor risk factors should caution the use of a probiotic (Boyle, Robins-
Browne & Tang, 2006) 
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Appendix 2: Survey Questions:  
 
1. Which of the following statements apply to your advice to patients regarding probiotics: 
a) I know of no reason to advise patient to take probiotics. 
b) Probiotic usage may be valid but I have not advised patients on these supplements 
c) I have advised patient on the value of taking probiotics 
 
2. Probiotics decrease the incidence of diarrhea: 
Yes No Don’t Know 
 
3. Probiotics decrease the risk of vaginitis due to yeast: 
Yes No Don’t Know 
 
4. Probiotics give a boost to host immunity 
Yes No Don’t Know 
 
 
Used with permission. 
Nichols, J. A. A., Grob, P. R., & Roche, N. (2005). A web questionnaire to determine the advice 
general practitioners give on probiotics. Journal of Nutritional & Environmental 
Medicine, 15(4) 212-222. doi:10.1080/13590840600692980. 
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Appendix 3 
PEMR Analytics Report Request 
Name:            Phone:      
              
Purpose of this report: 
 
 
              
Criteria:(please check all that apply and enter specific information in space provided) 











Include:  Deceased     Deactivated   Report Needed by:  Priority 
              
Desired Output: (Ex: Pt full name, MRN, DOB, Phone, A1c, Provider, Date of last arrived appt) 
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Appendix 5: Probiotic Handout for Patients 
 
What are probiotics? 
 Probiotics are bacteria found naturally in your large intestine.  By taking probiotics you 
maintain or restore the balance of bacteria normally found in your body.   
Why is my provider recommending I take a probiotic? 
 One of the side effects of antibiotics is diarrhea.  This is because antibiotics kill the 
infection you are being treated for as well as the normal bacteria found in your intestine.  When 
the normal bacteria are also wiped out diarrhea can occur.  The probiotics help to maintain the 
normal bacteria so you don’t get diarrhea. 
Where can I get probiotics? 
 Most of the pharmacies and grocery stores carry both name brand probiotics and store 
brand probiotics, either one is fine.  You may also look for probiotics at natural foods stores. 
How much do they cost? 
 The cost is $10 to $40 dollars depending on the brand and size of the bottle. 
How much should I take? 
 Your provider should tell you to either follow the package instructions or give you 
instructions on how many pills to take.  5 billion CFU are recommended but you should ask your 
provider how much you should take.  Your provider should discuss how long you should 
continue the probiotic, usually at least as long as you are on the antibiotic. 
When should I take them? 
 They should not be taken at the same time as the antibiotic but separated by 2 hours from 
your antibiotic dose. 
What are the side effects of probiotics? 
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 Probiotics are accepted as safe by the FDA.  However, some people may experience gas 
cramps and gas bloating from probiotics.  If this happens tell your provider.  This will often 
happen if you take more than the recommended dose.  
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Appendix 6: Email from Dr. John Nichols and Dr. Paul Grob 
----- Original Message -----  
From: John Nichols  
To: Liz Visone  
Sent: Wednesday, August 10, 2011 4:40 AM 
Subject: Fw: Fw: Web Questionnaire on Probiotics 
 
Dear Liz, 
My co-author has confirmed that you can use our q'aire in any way you wsh (see below). 
Good luck. 
John 
----- Original Message -----  
From: PAUL GROB  
To: John Nichols  
Sent: Wednesday, August 10, 2011 8:24 AM 
Subject: Re: Fw: Web Questionnaire on Probiotics 
hi fine 
paul 
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--- On Fri, 5/8/11, John Nichols <drjaan@ntlworld.com> wrote: 
 
From: John Nichols <drjaan@ntlworld.com> 
Subject: Fw: Web Questionnaire on Probiotics 
To: "Paul Grob" <paul.grob1@btinternet.com> 
Date: Friday, 5 August, 2011, 22:06 
Dear Paul, 
This American nurse practitioner would like to use part of our questionnaire. I have no problem 
with this. Is it OK by you? I will try to find out more about her project. 
Best wishes. 
John 
----- Original Message -----  
From: Liz Visone  
To: drjaan@ntlworld.com  
Sent: Thursday, July 28, 2011 2:04 AM 
Subject: Web Questionnaire on Probiotics 
 
Dear Dr. Nichols, 
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I am a doctoral student in the United States working my dissertation/capstone project for 
graduation. I would like to use parts of your questionnaire in my project. I found the first four 
questions in your article appropriate for my project as a pre and post test. I will be suggesting a 
practice guideline for use in an outpatient primary care practice. 
I would like to obtain permission to use your questions in my study, how would I go about doing 
this. Thank you for your help. 
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Appendix 7: Educational Intervention 
School of Nursing
The Use of Probiotics to Prevent Antibiotic 
Associated Diarrhea: 
Current Primary Care Practice and 
Introduction of an Evidence Based Practice 
Protocol
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2School of Nursing
Learning Objectives
 Understanding translational research
 Understanding normal gut ecology
 Understanding the effect antibiotics have on 
normal gut ecology
 Review of evidence of prophylactic probiotics 
to prevent antibiotic associated diarrhea
 Proposed evidence based protocol for the use 
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3School of Nursing
Translational Research
 This is research that moves the “bench 
experiment” to the bedside
 Taking current research and quickly moving it to 
the bedside
 Understanding that while rigor is important, 
there are many more variables at the bedside 
and many cannot be controlled
 How does laboratory knowledge translate with 
real patients under real life conditions
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4School of Nursing
Normal Gut Ecology
 The gut contain 300-500 different bacterial 
species
 30-40 species comprise the majority of bacteria
 Most of the gut bacteria is found in the colon
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5School of Nursing
Normal Gut Ecology
 pH in the stomach and small intestine prohibit 
bacterial colonization
 Unless you count Helicobacter pylori
 The entire community of bacteria in the gut has 
yet to be described
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6School of Nursing
Normal Gut Ecology
 Humans are born with a sterile gut
 Gut bacteria is populated during the birth 
process and neonatal period
 The initial ecology of the gut as an infant dictates 
the ecology as an adult
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7School of Nursing
Normal Gut Ecology
 The healthiest gut ecology is conferred by a 
vaginal birth and a breast fed infant
 Humans have a unique and stable gut ecology 
 Human gut bacterial flora is like a finger print, 
no two people have the same community 
members in the same concentration
 
  
USE OF PROBIOTICS TO PREVENT ANTIBIOTIC ASSOCIATED DIARRHEA  80 
8School of Nursing
Normal Gut Ecology
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9School of Nursing
Normal Gut Ecology












 Salvage of Energy
 
  












 The intestine has the highest concentration of 
immunocompetent cells in the body
 Interface between the body and the external 
environment
 Ecological communities of bacteria in the gut are a 
defense against invasion of exogenous microbes 
and thus prevent infection
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The Effect of Antibiotics on Gut Ecology
Antibiotics:
 Select for resistant organisms
 Inhibit susceptible organisms
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14School of Nursing
The Effect of Antibiotics on Gut Ecology
Alterations in Gut Mucosa:
 Changes in fermentation of carbohydrates and creation 
of mucous will change nutrient absorption ability of the 
host and inhibit immunological functions
 Abdominal pain most likely caused by diarrhea, bloating, 
and flatulence
 Selection of resistant organisms for continued growth 
produces an imbalance in the microflora
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The Effect of Antibiotics on Gut Ecology
Broad spectrum antibiotics are most 
often implicated
However
Any Antibiotic can cause AAD
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16School of Nursing
The Effect of Probiotics on Gut Ecology
A probiotic is defined by the World 
Health Organization as “Live 
microorganisms which when 
administered in adequate amounts 
confer a health benefit on the 
host.”
(World Health Organization, 2001)
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The Effect of Probiotics on Gut Ecology
 Support the native bacteria of the gut
 Preservation of the native bacterial community
 Encourage mucous production
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18School of Nursing
DEFINITION OF AAD
Antibiotic associated diarrhea 
(AAD) is the self limited diarrhea 
that occurs during or following a 
course of antibiotics 
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Incidence of AAD
 5-30% of adults prescribed an antibiotic
 301.4 out of 1000 adults were prescribed an 
antibiotic in the year 2002
 Resulting in 29 million adults in the US with 
AAD in the year 2002
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20School of Nursing
Incidence of AAD
 Current treatment for AAD is to stop the offending 
antibiotic
 Antibiotic treatment is necessary
 Prevention of AAD is a better choice
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21School of Nursing
Evidence for the use of Probiotics to 
Prevent AAD
No evidence based clinical guidelines available 
for the prevention in AAD in adults
Evidence based clinical guidelines are available 
for the pediatric population
7 meta-analyses and 1 RCT evaluated the 
efficacy of probiotics to prevent AAD
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META-ANALYSIS: Avadhani & Miley (2011)
 Consists of 8 RCT evaluating probiotic efficacy in the 
prevention of AAD
 Includes 2 RCT that report negative results 
 Focus was prevention of AAD & C. difficile in 
hospitalized adults
 Report a Relative Risk Ratio of 56%
 Conclude concurrent use of probiotics and antibiotics 
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META-ANALYSIS: Cremonini, et al (2002)
 Consists of 7 RCT evaluating probiotic efficacy in the 
prevention of AAD
 Includes 1 RCT that report negative results 
 Focus was prevention of AAD in an age range of 2 
weeks to elderly 
 Investigated probiotic monotherapy using 
Lactobacillus GG or S. Boulardii
 Conclude probiotics reduce the risk of AAD
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META-ANALYSIS: D’Souza, Rajkumar, 
Cooke, & Bullpitt (2002)
 Consists of 9 RCT evaluating probiotic efficacy in the 
prevention & treatment of AAD
 S. boulardii, lactobacilli or enterococci were 
evaluated 
 Focus was prevention of AAD in both adult and 
pediatric populations
 Relative Risk of 37% 
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META-ANALYSIS: Kale-Pradhan, Jassal & 
Wilhelm (2010)
 Consists of 10 RCT evaluating probiotic monotherapy 
efficacy in the prevention of AAD
 Lactobacillus was evaluated 
 Focus was prevention of AAD in both adult & 
pediatric populations, results were reported 
separately 
 Relative Risk of 24% 
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META-ANALYSIS: McFarland (2010)
 Systemic review & meta-analysis of S. boulardii in 
adults
 10 RCT using S. boulardii as monotherapy
 Focus was prevention of AAD in both adult & 
pediatric populations, results were reported 
separately 
 Relative Risk of 47% 
 Conclude S. boulardii prevents AAD in the adult 
population both in the inpatient & outpatient setting
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META-ANALYSIS: Sazawal, et al (2006) 
 Meta-analysis evaluated 16 RCT  focusing on the use 
of probiotics in all types of acute diarrhea 
 All RCT in the analysis were masked & placebo 
controlled
 Focus was prevention of acute diarrhea in both adult 
& pediatric populations
 Relative Risk reduction of 52% 
 Conclusion: of all types of acute diarrhea, probiotics 
have the greatest effect on preventing AAD
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META-ANALYSIS: Szajewska & Mrukowicz 
(2005) 
 Meta-analysis evaluated 5 RCT focusing on the use 
of S. boulardii for the prevention of AAD 
 Includes both adult & pediatric populations
 Relative Risk reduction of 43% 
 Conclusion: S. boulardii reduces the risk of AAD
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RCT: Armuzzi, et al (2001) 
 RCT with outpatient adults given probiotics during a 
specific antibiotic treatment
 Randomized 60 healthy asymptomatic H. pylori
positive adults to probiotic or placebo
 H. pylori treatment: raberprazole, clarithromycin, & 
tinidazole all BID 
 Lactobacillus GG (6x109 CFU) or placebo BID for 
14d; 1-1/2 hours after the antibiotic administration
 All the side effects of antibiotic use were included in 
the study, only diarrhea was significant (p=0.026)
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RCT: Armuzzi, et al (2001), continued
 Diarrhea rates reported: placebo 26.6% versus 
probiotic 3.3%
 Side effects were self reported and all diarrhea was 
reported as mild for all participants 
 Of note all the study participants were a convenience 
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Study Results
Avadhani & Miley (2011) concurrent use of probiotics and antibiotics as effective 
in preventing AAD in the hospitalized adult patient
Cremonini, et al (2002) Conclude probiotics reduce the risk of AAD
D’Souza, Rajkumar, Cooke, 
& Bullpitt (2002)
Conclude probiotics prevent AAD but do not treat AAD
Kale-Pradhan, Jassal & 
Wilhelm (2010)
Conclude probiotics prevent AAD in the adult population
McFarland (2010) Conclude S. boulardii prevents AAD in the adult 
population both in the inpatient & outpatient setting
Sazawal, et al (2006) Conclusion: of all types of acute diarrhea, probiotics 
have the greatest effect on preventing AAD
Szajewska & Mrukowicz
(2005) 
Conclusion: S. boulardii reduces the risk of AAD
Armuzzi, et al (2001) All the side effects of antibiotic use were included in the 
study, only diarrhea was significant (p=0.026)
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Conclusions
 All 7 meta-analyses and 1 RCT agree that AAD is 
prevented when probiotics are included in the 
treatment plan
 There is a wide variety of probiotics, diagnoses, 
antibiotics, patient populations and settings 
reported
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Conclusions
While there is no agreement on 
the best probiotic or the optimal 
dose there are some guidelines 
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Introduction of the Evidence-Based Protocol
Evidence-Based Protocol 
describing The Use of Probiotics 
in the Adult Outpatient 
Population
When an antibiotic is prescribed for any condition 
the following guidelines can be taken into 
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Introduction of the Evidence-Based Protocol
Strain
Lactobacillus, Bifdobacterium, S. boulardii are 
the most studied probiotics. 
(Avadhani & Miley, 2011; Cremonini, et al, 2002; Edwards-Marshall, 2011; Hickson, 
et al, 2007; Hunter, 2004; Rohde, Bartolini, & Jones, 2009; Santosa, Farnworth, & 
Jones, 2006; Vrabie & Aberra, 2009; Weichselbaum, 2009; Williams, 2010)
Culturelle, Align, Florastor or generic equivalent 
can be recommended since these OTC products 
contain one of the above mentioned probiotics.  
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Introduction of the Evidence-Based Protocol
Dose
1 million to 100 billion CFUs QD to BID. 
(Avadhani & Miley, 2011; Cremonini, et al, 2002; Fox & Dang, 2004; 
Hickson, et al, 2007; Rohde, Bartolini, & Jones, 2009; Santosa, 
Farnworth, & Jones, 2006; Wallace, 2009)
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Introduction of the Evidence-Based Protocol
Dose Timing
At least 2 hours from the dose of antibiotic.  This 
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Introduction of the Evidence-Based Protocol
Therapy Duration
At least during the antibiotic treatment course 
and up to 6 weeks after completion.  The 
average is 7-14 days.
(Edwards-Marshall, 2011; Cremonini, et al, 2002; Vrabie & Aberra, 2009)
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Introduction of the Evidence-Based Protocol
Contraindications
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Introduction of the Evidence-Based Protocol
Safety
Probiotics are generally considered safe.
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Introduction of the Evidence-Based Protocol
Risk Factors for Sepsis
 Major risk factors include: immune compromised 
individuals (including debilitated state or malignancy) 
and premature infants are at risk for sepsis 
 Minor risk factors include: central venous catheter, 
impaired intestinal epithelial barrier, administering 
probiotic by jejunostomy, broad spectrum antibiotic 
to which the probiotic is resistant, probiotics with 
high mucosal adhesions, use of Lactobacillius and 
cardiac valvular disease 
 The presence of one major risk factor and two or 
more minor risk factors should caution the use of a 
probiotic
(Boyle, Robins-Browne & Tang, 2006)
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How to document Probiotics in Allscripts®
 When you are picking the antibiotic in Allscripts®
medication section, you can also document the 
recommendation of a probiotic.  You can 
document just Probiotic or you can document a 
specific OTC probiotic.  
 If you search the term “probiotic” in the 
medication section the following screen shot is 
returned. You can select your favorites or just 
use the generic Probiotic.
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Screen Shot of Probiotic Search
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